1. Dual HER2 blockade in first line treatment of metastatic breast cancer – a population-based real world study. (March 2019) Authors: Birk Nielsen, L.; Knoop, A.; Berg, T.; Christensen, T. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Probing for corticotropin-releasing hormone (CRH) in human blood for doping control purposes using immunoaffinity purification and LC-HRMS/MS. Issue 29 (13th July 2017) Authors: Knoop, A.; Thomas, A.; Bidlingmaier, M.; Delahaut, P.; Schänzer, W.; Thevis, M. Journal: Analytical methods Issue: Volume 9:Issue 29(2017) Page Start: 4304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic and predictive impact of estrogen receptor alpha gene (ESR1) expression in postmenopausal women with early breast cancer: Results from the DBCG 77C trial. (March 2019) Authors: Nielsen, S.S.; Ejlertsen, B.; Jensen, M.-B.; Knoop, A.; Lænkholm, A.-V. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The effect of surveillance for symptomatic toxicities with real-time clinician reporting on dose reduction, hospitalization and febrile neutropenia in Danish breast cancer patients—a population-based cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). (April 2018) Authors: Pappot, H.; Bæksted, C.; Nissen, A.; Knoop, A.; Mitchell, S.; Christensen, J.; Johansen, C. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗